Abstract
The major mechanism of fluoroquinolone (FQ) resistance in Pseudomonas aeruginosa (PSA) is modification of target proteins in DNA gyrase and topoisomerase IV, most commonly the gyrA and parC subunits. The objective of this study was to determine risk factors for PSA with and without gyrA or parC mutations. Case-case-control study Two adult academic acute-care hospitals Case 1 study participants had a PSA isolate on hospital day 3 or later with any gyrA or parC mutation; case 2 study participants had a PSA isolate on hospital day 3 or later without these mutations. Controls were a random sample of all inpatients with a stay of 3 days or more. Each case group was compared to the control group in separate multivariate models on the basis of demographics and inpatient antibiotic exposure, and risk factors were qualitatively compared. Of 298 PSA isolates, 172 (57.7%) had at least 1 mutation. Exposure to vancomycin and other agents with extended Gram-positive activity was a risk factor for both cases (case 1 odds ratio [OR], 1.09; 95% confidence interval [CI], 1.04-1.13; OR, 1.14; 95% CI, 1.03-1.26; case 2 OR, 1.09; 95% CI, 1.03-1.14; OR, 1.13; 95% CI, 1.01-1.25, respectively). Exposure to agents with extended Gram-positive activity i...Continue Reading
References
Jan 1, 1989·American Journal of Epidemiology·R M Mickey, S Greenland
Aug 1, 1996·Journal of Clinical Epidemiology·G W SunG L Kay
Oct 1, 1995·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·L M BaddourB G Painter
Feb 7, 1998·Medical Care·A ElixhauserR M Coffey
Feb 13, 1999·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·S Jalal, B Wretlind
Apr 2, 1999·Antimicrobial Agents and Chemotherapy·S BagelP Heisig
May 21, 1999·Archives of Internal Medicine·Y CarmeliM H Samore
Apr 24, 2001·American Journal of Therapeutics·W KhayrA Walters
Jan 5, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Anthony D HarrisMary-Claire Roghmann
Feb 2, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David M Livermore
Feb 19, 2002·Antimicrobial Agents and Chemotherapy·Anthony D HarrisJudith A Johnson
Feb 28, 2002·The Journal of Antimicrobial Chemotherapy·Yan Zhi QiangGong Yi
Jul 31, 2003·The Journal of Antimicrobial Chemotherapy·Joseph A PaladinoJerome J Schentag
Jun 9, 2004·The Journal of Hospital Infection·B CaoM Chen
Feb 25, 2005·The Journal of Antimicrobial Chemotherapy·Donald I HsuAnnie Wong-Beringer
Mar 24, 2005·International Journal of Antimicrobial Agents·Jeom Kyu LeeBong Su Kim
Mar 29, 2005·Antimicrobial Agents and Chemotherapy·Scott T MicekMarin H Kollef
May 4, 2005·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Keith S KayeYehuda Carmeli
Aug 19, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Robert GaynesUNKNOWN National Nosocomial Infections Surveillance System
Dec 27, 2005·Antimicrobial Agents and Chemotherapy·Valerie AloushYehuda Carmeli
Jun 6, 2006·The American Journal of Medicine·Stefan StörkMichiel L Bots
Jun 6, 2006·The American Journal of Medicine·Leanne B GasinkEbbing Lautenbach
Aug 31, 2006·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Ebbing LautenbachNeil O Fishman
Aug 7, 2009·International Journal of Antimicrobial Agents·Neda GorganiNader Pourmand
Nov 16, 2010·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Po-Ren HsuehLee-Jene Teng
Mar 29, 2014·TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·Bilal H AshrafLuc L Janss